Australia’s Innovation Gap: Predictive Health Tools Developed But Rarely Used in Clinical Practice
A systematic review from Curtin University reveals that Australia has developed multiple predictive health tools for serious conditions, yet few…
Editor's Top Picks
Germany’s Sick Note Policy Sparks Medical Ethics Debate Over Patient Access
Germany's proposed requirement for workers to obtain medical sick notes on the first day of illness has drawn sharp criticism…
Submit Your Paper to GMJ
CBD Shows Promise in Reducing Alzheimer’s-Related Brain Inflammation
New preclinical research suggests CBD may help fight Alzheimer's disease by reducing neuroinflammation in mouse models. The study found that…
Bronchial Anthracosis: Coal Dust Exposure Leaves Distinctive Lung Patterns
A New England Journal of Medicine case demonstrates bronchial anthracosis, where coal dust creates distinctive black patterns in lung airways.…
Osteomyelitis: New Global Evidence on Diagnosis and Treatment of Bone Infections
A comprehensive new review in Nature Reviews Disease Primers reveals that adults over 50 face the highest osteomyelitis risk at…
China’s Infectious Disease Burden Drops by Half Since 2000, But Age-Related Challenges Emerge
China achieved a 50% reduction in infectious disease burden from 2000-2023, but progress was uneven with elderly populations now bearing…
Regional Nerve Block Reduces Opioid Use After Heart Surgery by 25%, Multicentre Trial Shows
A multicentre randomised trial shows bilateral nerve blocks with ropivacaine reduce opioid consumption by 25% after cardiac surgery. The EPOCH…
Mental health interventions show promise for extreme weather trauma recovery
Mental health interventions demonstrate significant effectiveness in reducing PTSD, depression, and anxiety symptoms among people affected by extreme weather events.…
Experimental Drug Shows 96% Viral Suppression in Hepatitis B Clinical Trial
Clinical trial shows experimental drug bepirovirsen achieves 96% viral suppression when combined with standard hepatitis B therapy. Phase III trials…
World’s Largest Longevity Competition Targets Age Reversal Breakthroughs
The XPRIZE Healthspan competition offers $101 million in prizes for age reversal breakthroughs targeting cognitive, muscle, and immune function. Dr.…